Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.
about
Levosimendan: current data, clinical use and future developmentAgents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyondEmerging Novel Therapies for Heart FailureManagement of end-stage heart failure: a perspective on the Arab Gulf statesAdvanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.Inotropes do not increase mortality in advanced heart failureRole of inotropic agents in the treatment of heart failure.Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with IsoproterenolDesign of therapy for advanced heart failure.The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.An overview of inotropic agents.Are scores useful in advanced heart failure?Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents.Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.Symptom management challenges in heart failure: pharmacotherapy considerations.Cardiac gene therapy: kick-starting calcium cycling in rats.Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardium.
P2860
Q24629274-3BC37DCB-645E-4279-AF56-0935EE86B635Q24645066-E1808267-5193-4453-8E98-B14137B5C920Q26778111-2ED5D783-FD16-44BC-BF7D-E98C2A2AF5BAQ28751716-7F3398C8-8BD0-4502-A43D-1E1EEE659FC3Q30394479-1E7FAB9C-942A-4434-823B-F9B632AB79B2Q33685748-68C37A0F-0738-4D80-AC78-5EFFFA628B4FQ33816527-E00EB320-6DB7-4A7B-A2F8-2B310ABEEA2EQ34191737-40D2CF6E-F42B-4E24-B9AB-E92E5864EF78Q35722861-F798B0F5-949D-46DF-BCE6-9B7EE5800159Q36046596-F9FDE67B-80BE-483C-96B5-423DF4547966Q36266387-E4236A8B-A38F-43FD-A00F-F965525F8390Q36588715-FCCCEC6A-ED15-48B6-8946-E25E3E0126F5Q37578565-BFD345BB-B764-4080-8217-12E9F490350DQ37682472-D9D0E3FD-5D9A-4366-8455-6E9605BDDF4BQ37858515-AB5EE796-DA37-4F5E-BB75-BFF4BD507291Q38108536-86755DC3-6805-4541-85BC-15C8DB7923BCQ39395575-710C0048-DA9B-4874-8D2E-9F9DBD208AD6Q45883073-404BF037-E1FE-4286-BDE7-8073A35EC928Q47860273-C7926622-0DDD-488B-A192-C9B7816A69C4Q54600220-504DBB6C-E269-46AF-9117-3C3C524ABF85
P2860
Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical use of inotropic ther ...... usions during hospitalization.
@ast
Clinical use of inotropic ther ...... usions during hospitalization.
@en
type
label
Clinical use of inotropic ther ...... usions during hospitalization.
@ast
Clinical use of inotropic ther ...... usions during hospitalization.
@en
prefLabel
Clinical use of inotropic ther ...... usions during hospitalization.
@ast
Clinical use of inotropic ther ...... usions during hospitalization.
@en
P1433
P1476
Clinical use of inotropic ther ...... usions during hospitalization.
@en
P2093
Lynne Warner Stevenson
P304
P356
10.1161/01.CIR.0000078348.44634.BA
P407
P577
2003-07-01T00:00:00Z